Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / April / Hidden Resistance in Newborns
Screening and monitoring Clinical care Genetics and epigenetics Molecular Pathology

Hidden Resistance in Newborns

Study detects antibiotic resistance genes in infants within hours of birth

04/29/2026 News 2 min read

Share

Credit: AdobeStock.com

A study presented at ESCMID Global 2026 has found that antibiotic resistance genes can be present in newborns within the first hours of life, highlighting how early exposure to resistant bacteria may occur (1).

Researchers analyzed meconium samples – the first stool passed by newborns – from 105 infants admitted to a neonatal intensive care unit (NICU) within 72 hours of birth. Meconium was once thought to be sterile, but modern molecular testing has shown that microbial genetic material can be present at this stage.

Using molecular methods, the team screened for 56 resistance genes linked to commonly used antibiotics. Most infants carried multiple resistance genes, with a median of eight detected per sample. The most common genes were associated with resistance to widely used antibiotics, and genes linked to resistance to last-line treatments, such as carbapenems, were also identified in a proportion of cases.

These findings suggest that the neonatal gut may already contain a range of resistance genes at birth. Importantly, this does not mean the infants have infections, but it indicates the presence of genetic material that could contribute to antibiotic resistance if transferred between bacteria.

The study also identified factors linked to the presence of these genes. Maternal hospitalization during pregnancy and early medical interventions, such as central line placement, were associated with higher numbers of resistance genes. This suggests that both maternal factors and early hospital exposure may influence the types of microbes and resistance genes present in newborns.

The study highlights the value of molecular testing in detecting resistance genes that would not be identified using standard culture-based methods. It also shows that early-life samples may provide useful information about microbial exposure and resistance patterns.

The findings reinforce the importance of infection prevention and antimicrobial stewardship in neonatal care. Monitoring resistance patterns at an early stage may help improve understanding of how resistance develops and spreads.

Overall, the study indicates that exposure to antibiotic resistance can begin very early in life, and that molecular diagnostics can play an important role in identifying and tracking these patterns.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. A Ftergioti et al., “Antibiotic resistance genes in meconium of newborns very early after admission to neonatal intensive care unit” (2026). Study presented at ESCMID Global, April 20, 2026, Munich, Germany.

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Flexible Solutions With FlexVUE
Screening and monitoring
Flexible Solutions With FlexVUE

December 29, 2021

1 min read

Quickly customize your immune panels with Ultivue’s new innovation

What’s New in Infectious Disease? (December 2021)
Screening and monitoring
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

A Pig In a Poke
Screening and monitoring
A Pig In a Poke

October 21, 2016

1 min read

When importing livestock for food or breeding, European countries may inadvertently open their borders to superbugs as well

Sneaky Superbugs
Screening and monitoring
Sneaky Superbugs

October 21, 2016

1 min read

Norway’s strict LA-MRSA transmission measures prevent the import of almost all live pigs – but the bacteria have found a new way in

Affiliations:

Specialties:

Areas of Expertise:

View Full Profile Follow
Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.